Literature DB >> 30475385

RNA is taking its Toll: Impact of RNA-specific Toll-like receptors on health and disease.

Tim Vierbuchen1, Karina Stein1,2, Holger Heine1,2.   

Abstract

RNA-sensing Toll-like receptors (TLRs) are often described as antiviral receptors of the innate immune system. However, the past decade has shown that the function and relevance of these receptors are far more complex. They were found to be essential for the detection of various bacterial, archaeal, and eukaryotic microorganisms and facilitate the discrimination between dead and living microbes. The cytokine and interferon response profile that is triggered has the potential to improve the efficacy of next-generation vaccines and may prevent the development of asthma and allergy. Nevertheless, the ability to recognize foreign RNA comes with a cost as also damaged host cells can release nucleic acids that might induce an inappropriate immune response. Thus, it is not surprising that RNA-sensing TLRs play a key role in various autoimmune diseases. However, promising new inhibitors and antagonists are on the horizon to improve their treatment.
© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  RNA; TLR8; archaea; infection; vaccines

Mesh:

Substances:

Year:  2018        PMID: 30475385     DOI: 10.1111/all.13680

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

Review 1.  Sex disparities matter in cancer development and therapy.

Authors:  Sue Haupt; Franco Caramia; Sabra L Klein; Joshua B Rubin; Ygal Haupt
Journal:  Nat Rev Cancer       Date:  2021-04-20       Impact factor: 60.716

2.  A Non-Invasive Neonatal Signature Predicts Later Development of Atopic Diseases.

Authors:  Youssouf Sereme; Moïse Michel; Soraya Mezouar; Cheick Oumar Guindo; Lanceï Kaba; Ghiles Grine; Thibault Mura; Jean-Louis Mège; Tu Anh Tran; Pierre Corbeau; Anne Filleron; Joana Vitte
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

Review 3.  Methanogenic Archaea: Emerging Partners in the Field of Allergic Diseases.

Authors:  Youssouf Sereme; Soraya Mezouar; Ghiles Grine; Jean Louis Mege; Michel Drancourt; Pierre Corbeau; Joana Vitte
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

4.  Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.

Authors:  Wesley de Jong; Lorna Leal; Jozefien Buyze; Pieter Pannus; Alberto Guardo; Maria Salgado; Beatriz Mothe; Jose Molto; Sara Moron-Lopez; Cristina Gálvez; Eric Florence; Guido Vanham; Eric van Gorp; Christian Brander; Sabine Allard; Kris Thielemans; Javier Martinez-Picado; Montserrat Plana; Felipe García; Rob A Gruters
Journal:  Vaccines (Basel)       Date:  2019-12-06

5.  Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity.

Authors:  Chu-Wen Yang; Mei-Fang Chen
Journal:  PeerJ       Date:  2021-02-24       Impact factor: 2.984

Review 6.  RNA Binding Proteins as Pioneer Determinants of Infection: Protective, Proviral, or Both?

Authors:  Samantha Lisy; Katherine Rothamel; Manuel Ascano
Journal:  Viruses       Date:  2021-10-28       Impact factor: 5.048

Review 7.  Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.

Authors:  Elena Layunta; Berta Buey; Jose Emilio Mesonero; Eva Latorre
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

Review 8.  Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges.

Authors:  Victor E Nava; Pin-Yu Perera; Nirbhay Kumar; Maneesh Jain
Journal:  Vaccines (Basel)       Date:  2022-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.